Mavaddat, N, Barrowdale, D, Andrulis, IL, Domchek, SM, Eccles, D
, Nevanlinna, H, Ramus, SJ, Spurdle, A, Robson, M, Sherman, M, Mulligan, AM, Couch, FJ, Engel, C, McGuffog, L, Healey, S, Sinilnikova, OM, Southey, MC, Terry, MB, Goldgar, D, O'Malley, F, John, EM, Janavicius, R, Tihomirova, L, Hansen, TVO, Nielsen, FC, Osorio, A, Stavropoulou, A, Benitez, J, Manoukian, S, Peissel, B, Barile, M, Volorio, S, Pasini, B, Dolcetti, R, Putignano, AL, Ottini, L, Radice, P, Hamann, U, Rashid, MU, Hogervorst, FB, Kriege, M, van der Luijt, RB, Peock, S, Frost, D, Evans, DG, Brewer, C, Walker, L, Heikkinen, T
, Heikkila, P, Aittomaki, K & EMBRACE, Consortium Investigators Modifiers, SWE-BRCA Collaborators, HEBON, kConFab Investigators, GEMO Study Collaborators 2012, '
Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)',
Cancer Epidemiology, Biomarkers & Prevention, vol. 21, no. 1, pp. 134-147.
https://doi.org/10.1158/1055-9965.EPI-11-0775